StockData
VolitionRx Ltd logo

VolitionRx Ltd (VNRX) shareholders

VNRXNYSEIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$0.19−0.01 (-5.56%)

Close on Nov 17, 2026Market cap $2.58MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
14.1%
2M of 14M shares
Institutional holders
25
5 new, 11 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Armistice Capital, LLC
Joint filing with Steven Boyd (9.99%)
9,343,2659.99%13G (passive) amendmentDec 31, 2024
Fatima Dickey
Joint filing with Lagoda Investment Management, L.P. (5.90%), Lagoda Investment Management, LLC (5.90%)
1,650,5055.90%13D (active) amendmentSep 15, 2026
Lagoda Investment Management, L.P.1,627,00514.00%13G (passive) amendmentJun 30, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of VNRXValueChange% of portfolio
Lagoda Investment Management, L.P.1,455,95010.67%$1.97M+648,5001.08%
Luminus Management LLC156,8971.15%$211.81K+107,1470.14%
Geode Capital Management, LLC55,5370.41%$74.99K−5,9670.00%
Vanguard Capital Management LLC50,6840.37%$68.42K–0.00%
Wealthspire Advisors, LLC45,0000.33%$60.75K+34,0000.00%
State Street Corp33,9950.25%$45.89K−20.00%
XTX Topco Ltd25,3810.19%$34.26K+23,0780.00%
Vanguard Fiduciary Trust Co25,1330.18%$33.93K–0.00%
BlackRock, Inc.22,3080.16%$30.12K−10.00%
Northern Trust Corp12,9780.10%$17.52K−20.00%
Silverberg Bernstein Capital Management LLC12,5200.09%$16.90K−410.01%
Squarepoint Ops LLC10,6850.08%$14.43KNew0.00%
Tower Research Capital LLC (TRC)5,7680.04%$7.79K+3,9520.00%
SRS Capital Advisors, Inc.5,5520.04%$7.50KNew0.00%
UBS Group AG4,4190.03%$5.97K−5,9530.00%
Group One Trading, L.P.2,5000.02%$3.38K–0.00%
Simplex Trading, LLC2,1740.02%$2.93KNew0.00%
Northwestern Mutual Wealth Management Co1,9990.01%$2.70K−10.00%
Integrated Wealth Concepts LLC1,0000.01%$1.35K+5000.00%
Barclays PLC3570.00%$482New0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026252M14.1%5 / 88 / 111M0M
Q1 2026311M8.2%12 / 101 / 80M0M
Q4 2025281M5.9%6 / 97 / 110M1M
Q3 2025331M9.6%7 / 134 / 30M0M
Q2 2025291M8.8%9 / 74 / 50M0M
Q1 2025251M7.7%4 / 86 / 60M0M
Q4 2024271M6.8%8 / 75 / 30M0M
Q3 2024221M6.4%4 / 74 / 81M0M
Q2 2024270M2.9%7 / 76 / 40M0M
Q1 2024240M3.0%2 / 86 / 60M0M
Q4 2023280M2.4%4 / 105 / 60M0M
Q3 2023300M2.3%3 / 58 / 60M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

5 funds held VNRX in Q2 2026, 53% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of VNRXValue% of fundAs of
Vanguard Extended Market Index Fund50,6840.37%$68.42K0.00%Jun 30, 2026
Fidelity Extended Market Index Fund31,7760.23%$84.84K0.00%May 31, 2026
Fidelity Total Market Index Fund7,0370.05%$18.79K0.00%May 31, 2026
Fidelity Series Total Market Index Fund5,7750.04%$15.42K0.00%May 31, 2026
Total Stock Market Index Trust5880.00%$7940.00%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Cameron John ReynoldsPresident and CEO, Director4,157,34130.46%Feb 27, 2026
Ann-Louise BatchelorGroup Chief Marketing Officer29,2570.21%Oct 23, 2026
Gaetan MichelChief Operating Officer12,2320.09%Sep 30, 2026
Gael ForterreChief Commercial Officer18,1590.13%Sep 30, 2026
Nicholas PlummerGC - Volition Diagnostics407,2672.98%Mar 19, 2026
Rodney Gerard RootsaertSecretary1,281,7119.39%Mar 19, 2026
Jacob Vincent MicallefChief Scientific Officer665,2924.87%Mar 19, 2026
Terig HughesChief Financial Officer684,9705.02%Feb 27, 2026
Jasmine KwayCEO - Singapore Volition429,0143.14%Feb 27, 2026
Salvatore Thomas ButeraCEO - Volition Veterinary375,2032.75%Jan 23, 2026
Andrew RetterChief Medical Officer146,5681.07%Nov 4, 2025
Guy Archibald InnesDirector3,317,97424.31%Feb 27, 2026
Ethel RubinDirector252,9481.85%Feb 27, 2026
Kim NguyenDirector336,3722.46%Feb 27, 2026
Timothy I. StillDirector1,625,45811.91%Jan 23, 2026
Phillip BarnesDirector67,3680.49%Jan 23, 2026
Mickie HenshallDirector44,2060.32%Jan 23, 2026
Alan ColmanDirector257,3641.89%Jan 23, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Ann-Louise Batchelor
Group Chief Marketing Officer
Oct 21, 2026Award+12,000––27,786
Gael Forterre
Chief Commercial Officer
Sep 28, 2026Tax withholding−284$0.25$7116,284
Gaetan Michel
Chief Operating Officer
Sep 28, 2026Tax withholding−608$0.25$15212,232
Gael Forterre
Chief Commercial Officer
Mar 17, 2026Tax withholding−5,251$0.19$998331,338
Rodney Gerard Rootsaert
Secretary
Mar 17, 2026Tax withholding−3,948$0.19$750273,993
Nicholas Plummer
GC - Volition Diagnostics
Mar 17, 2026Tax withholding−7,003$0.19$1.33K407,267
Jacob Vincent Micallef
Chief Scientific Officer
Mar 17, 2026Tax withholding−5,310$0.19$1.01K572,179
Gael Forterre
Chief Commercial Officer
Mar 1, 2026Tax withholding−2,283$0.21$479336,589
Nicholas Plummer
GC - Volition Diagnostics
Mar 1, 2026Tax withholding−5,867$0.21$1.23K414,270
Rodney Gerard Rootsaert
Secretary
Mar 1, 2026Tax withholding−3,321$0.21$697277,941
Terig Hughes
Chief Financial Officer
Feb 26, 2026Award+202,000––684,970
Rodney Gerard Rootsaert
Secretary
Feb 26, 2026Award+119,000––281,262
Nicholas Plummer
GC - Volition Diagnostics
Feb 26, 2026Award+187,000––420,137
Jacob Vincent Micallef
Chief Scientific Officer
Feb 26, 2026Award+149,000––577,489
Guy Archibald Innes
Director
Feb 26, 2026Award+178,000––1,252,967
Ann-Louise Batchelor
Group Chief Marketing Officer
Feb 26, 2026Award+142,000––324,072
Cameron John Reynolds
President and CEO, Director
Feb 26, 2026Award+486,000––3,115,547
Jasmine Kway
CEO - Singapore Volition
Feb 26, 2026Award+173,000––418,614
Ethel Rubin
Director
Feb 26, 2026Award+178,000––252,948
Kim Nguyen
Director
Feb 26, 2026Award+178,000––305,816
Gael Forterre
Chief Commercial Officer
Feb 26, 2026Award+149,000––338,872
Gael Forterre
Chief Commercial Officer
Feb 1, 2026Tax withholding−2,010$0.29$583189,872
Nicholas Plummer
GC - Volition Diagnostics
Feb 1, 2026Tax withholding−5,647$0.29$1.64K233,137
Rodney Gerard Rootsaert
Secretary
Feb 1, 2026Tax withholding−3,196$0.29$927162,262
Terig Hughes
Chief Financial Officer
Jan 22, 2026Award+49,200––482,970
Gael Forterre
Chief Commercial Officer
Jan 22, 2026Award+38,100––191,882
Salvatore Thomas Butera
CEO - Volition Veterinary
Jan 22, 2026Award+53,400––375,203
Jacob Vincent Micallef
Chief Scientific Officer
Jan 22, 2026Award+35,400––428,489
Guy Archibald Innes
Director
Jan 22, 2026Award+12,000––1,074,967
Rodney Gerard Rootsaert
Secretary
Jan 22, 2026Award+28,200––165,458
Jasmine Kway
CEO - Singapore Volition
Jan 22, 2026Award+42,000––245,614
Phillip Barnes
Director
Jan 22, 2026Award+12,000––67,368
Kim Nguyen
Director
Jan 22, 2026Award+12,000––127,816
Ann-Louise Batchelor
Group Chief Marketing Officer
Jan 22, 2026Award+33,900––182,072
Timothy I. Still
Director
Jan 22, 2026Award+90,000––1,625,458
Nicholas Plummer
GC - Volition Diagnostics
Jan 22, 2026Award+44,700––238,784
Mickie Henshall
Director
Jan 22, 2026Award+12,000––44,206
Ethel Rubin
Director
Jan 22, 2026Award+12,000––74,948
Alan Colman
Director
Jan 22, 2026Award+12,000––257,364
Cameron John Reynolds
President and CEO, Director
Jan 22, 2026Award+74,700––2,629,547
Cameron John Reynolds
President and CEO, Director
Nov 17, 2025Buy+20,000$0.35$7.00K2,554,847
Rodney Gerard Rootsaert
Secretary
Nov 1, 2025Tax withholding−3,197$0.43$1.37K137,258
Nicholas Plummer
GC - Volition Diagnostics
Nov 1, 2025Tax withholding−5,647$0.43$2.43K194,084
Salvatore Thomas Butera
CEO - Volition Veterinary
Nov 1, 2025Tax withholding−4,648$0.43$2.00K321,803
Andrew Retter
Chief Medical Officer
Nov 1, 2025Tax withholding−4,588$0.43$1.97K146,568
Gael Forterre
Chief Commercial Officer
Nov 1, 2025Tax withholding−1,753$0.43$754153,782
Guy Archibald Innes
Director
Oct 14, 2025Buy+96,153$0.51$49.04K1,062,967
Timothy I. Still
Director
Oct 14, 2025Buy+48,076$0.51$24.52K1,535,458
Cameron John Reynolds
President and CEO, Director
Oct 14, 2025Buy+110,000$0.51$56.10K2,534,847
Salvatore Thomas Butera
CEO - Volition Veterinary
Oct 4, 2025Tax withholding−5,834$0.65$3.79K326,451
Gaetan Michel
Chief Operating Officer
Oct 4, 2025Tax withholding−12,333$0.65$8.02K256,746
Ann-Louise Batchelor
Group Chief Marketing Officer
Oct 4, 2025Tax withholding−6,110$0.65$3.97K148,172
Jacob Vincent Micallef
Chief Scientific Officer
Oct 4, 2025Tax withholding−5,850$0.65$3.80K393,089
Gael Forterre
Chief Commercial Officer
Oct 4, 2025Tax withholding−5,389$0.65$3.50K155,535
Rodney Gerard Rootsaert
Secretary
Oct 4, 2025Tax withholding−4,620$0.65$3.00K140,455
Nicholas Plummer
GC - Volition Diagnostics
Oct 4, 2025Tax withholding−8,146$0.65$5.29K199,731
Gaetan Michel
Chief Operating Officer
Sep 28, 2025Tax withholding−11,362$0.61$6.93K369,079
Gael Forterre
Chief Commercial Officer
Sep 28, 2025Tax withholding−5,503$0.61$3.36K160,924
Rodney Gerard Rootsaert
Secretary
Sep 28, 2025Tax withholding−4,158$0.61$2.54K145,075
Salvatore Thomas Butera
CEO - Volition Veterinary
Sep 28, 2025Tax withholding−5,230$0.61$3.19K332,285

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
10.23%
1M shares short
Days to cover
1.2
At 1M shares a day
Change since last report
+21.9%
From 1M shares
Short volume, 20 days
53.6%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of VolitionRx's stock actually held short. Settlement fails (shares not delivered on time) peaked at 7,068,460 shares on Aug 28, 2026 over the last 90 days.

See a number that looks wrong?